Linda Enjema is a Atlanta, Georgia based nurse practitioner. Active license number of Linda Enjema is RN274835 for Family in Georgia. Her current practice location is 4938 Zoya Ct Sw, Atlanta. Patients can reach her at 404-729-5437 or can fax her at 404-745-8399 and her NPI number (Unique professional ID assigned by NPPES) is 1720659980. Linda Enjema has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Linda Enjema speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1720659980
NPI Enumeration Date:
08 Jul, 2021
NPI Last Update On:
27 Mar, 2025
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Linda Enjema are as mentioned below.
License Number
Specialization
State
Status
RN274835
Family
Georgia
Primary
RN274835
Family Medicine
Georgia
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Linda Enjema 4938 Zoya Ct Sw, Atlanta, Georgia
Zip:
30331-7527
Phone Number:
404-729-5437
Fax Number:
404-745-8399
Patients can reach Linda Enjema at 4938 Zoya Ct Sw, Atlanta, Georgia or can call to book an appointment on 404-729-5437.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 April, 2025.